Member Info for Indiscipline

I think that's exactly what is planned put two pharma solutions with a diverse range of benefits set them up independently and if successful shareholders can have a company that is independent and the potential to acquire and grow further.

We have stock interest but maintain our neutral status and take dividends as and when. CF seemed to be intimating that was the most likely option with Imutex if you add in Prep where we are the majority owner the company looks very attractive as a float.

I wish I could afford that amount in all seriousness. I am percentage wise deep here. Just wish I was deeper...
Nearly all look on the price here and think come late Jan at the latest we will see massive uplift.
By late March we will have Wearables, more Venn data deals, Imutex and a welter more of contracts hit... not even adding in more facilities as they may drop a little later.

We really have not got long to wait.

Then if you got your answer Mr Soros you were wasting everyone's time asking the question. Go and do your deramp somewhere else...

As for losers the stock is up over 400% in a year. Unlikely next year but with Venn datbase, Imutex and other contracts hitting shareholders here will make out just fine. Now you can close the door behind you when you leave - bye bye mate.

Bronx ur cr*pping yourself. Email CF or:

Sell and move on. There has been accumulation and distribution. When we went through the LInk mess it happened.
There will be more. This is churn time. If you don't like it take your profits and move on.

January is coming and institutions will be doing this through this point in the market. Generally stocks reflect increasing earnings and this stock is and has an opportunity with even more contracts secured to increase earnings substantially.

Obviously we have been in a downtrend. Otherwise we would have gone straight up. However 22-26p has been a classic consolidation phase like most stocks in a secular uptrend have.

Chartwise the long term trend from April has not been broken through this phase. It would have to break below 20p to do that. This is a classic stair step pattern. There have been earlier some sells as I said. However, we also have had some accumulation - books are being readied for the new year.

The unthinking bidding up of anything covid is over. Stocks are getting assessed which long term suits us just fine. We have probably got another week or twos of churn till Jan gets underway and positions have been finalised. The key is how we move through the consolidation phase. Breaking 26p and moving on tells you the next leg up has begun.

The contracts keep kicking in and the new studies being developed bode well. CF is developing them after speaking to the clients not before. New management know where to place horses and carts and do this very effectively. The market will analyse us after Xmas and I think we will come out more than fine.

If you look on the trades section there has definitely been some decent buying. A few would be sells but block buys show accumulation is taking place otherwise we would have cratered. The year end window dressing has been handled well.

We got the approval - we can now collect the contracts and move onwards and upwards. We have consolidated and are now ready for the next leg up. This time of year gets choppy but we have a very positive year ahead. New contracts, new studies and new company Imutex or sale.

The ii's and retail balancing the books which is their right. We all have different perspectives and needs.
Some guys have sold down there has also been accumulation.

When the Challenge approvals drop then we get the next lift off. This is a consolidation phase as we wait for the next key news to hit. Like deep I am happy to hold for the next move which is likely in January. Loads of news and deals to hit...

He has in presentation after presentation...

Great post deepjoy great to have you post more regularly and that is not a rant Demon.

I think you are right we are losing or have lost the quick buck merchants which is no bad thing. The company as a whole is developing nicely.

What is heartening is that the deals are not being rushed. Imutex will not be quickly offloaded for a cheap price. As for wearbles CF taking his time to structure the deal.

The studies are being extended and no pointless acquisitions but concentrating on the game in hand. The antibacterial studies could flood the company with cash. CF looking more and more and realising the real potential of this company to generate great returns.

We are building a great base chart wise and cash wise. By February this stock will comfortably in the thirties as new institutions come on board and new investors.

We have MS trials for Forlumab in January.

It's ridiculous that investors have to speculate on whether or not Bids is getting paid. There should be proper communication with shareholders at regular intervals. Shareholders own the company and have no right to be constantly for a year kept in the dark on all matters.

Your points are very well made.

We do also need timescale for approval of testing. When that occurs contracts kick in.
Though he's banging them out as we wait.

Ex looks like you may be needed to get the rounds in... Being cost conscious I will only ask for a Dom Perignon from your goodself... Don't want to be too greedy...

1.92% up.
"C'mon feel the noise...C'mon everyone. We get wild, wild wild..."

3.2% now. I think Noddy' son broke the downtrend... I love you J.

No worries..

You do seem a little worried from your posting. All shares have risk attached, if you are just top slice so you can enjoy the ride over what looks like an exciting time with many opportunities to succeed.

Thanks for your apology it was very gracious. All the best.

The horror is that this virus will be with us in one form or another for years... Second and third gen vaccines are needed.
On top of this CF is developing other studies for other key virals that pharma are looking to test.

He also mentioned anti-biotics and bacterials where strains are becoming increasingly resistant. Huge scope in this area.

I see now either... A) you can't read English
B)You are a complete liar....

Look at the post never said it... Stated a third facility on its way. Deramp plays work best when you try to appear genuine.
But originally your deramp was a subtle one which I admired...I was applauding your work.

I love seeing the art of the subtle de-ramper on here. In his last interview 36 hours ago on Vox, he stated categorically that they were organising the third facility,

Your posts are all little de-ramps in the guise of an investor. Nice work...

We need that approval given. That occurs everything shoots up. Also getting shot because we are seen as covid play and asset managers looking at re-opening plays more and more. The fact is Vaccines are where it's at. Vaccine testing as CF and numerous articles (unearthed by excellent members of this board) show is a key growth area for the years ahead.

CF is not organising a third testing facility cos he likes chucking money around for the sake of it. He has the orders coming in to utilise it. December could be tight as books get balanced. Come January this company will be out the blocks fast with even more cash hitting the balance sheet.

Profitable company with ever growing profit centres...

You just have to hold an amount that you can stomach. There may or may not be one more large shakeout.

What I did was look at the videos to remind myself the areas we are involved in and the multiple shots we have to make money. Would like to add more but mental health trumps profit right now. The fact is by Feb we will have Foralumab results and be into the MS trials those alone could send this stock multiples and multiples higher. That is just the start of the pipeline.

The amount of IP they have backing up their drug pipeline is astonishing. Shortly we will see if they can deliver.
You can have strong communicators but if they can't get a team of heavy hitting scientists you have nothing.
If the science is right the business can quickly be streamlined but not vice versa.